Stratification by myocardial ECV (≤43% defining low burden) enabled phenotyping of earlier-stage ATTR-CA, which can resemble HHD or mild HCM on conventional imaging. Basal inferolateral/inferior LGE ...
A promising new way to diagnose transthyretin amyloid cardiomyopathy (ATTR-CM or -CA) has the field waiting in anticipation. Early-phase research suggests that the positron emission tomography ...
Primary care physicians (PCPs) are often the first to encounter patients with early cardiac amyloidosis, well in advance of when these patients are referred for advanced heart failure care. In ...
A quiet revolution in care is helping patients with cardiac amyloidosis, a form of heart failure that long stumped doctors. By Simar Bajaj When James Hicks, 75, was diagnosed with heart failure, it ...
An artificial intelligence (AI) model developed by Mayo Clinic and Ultromics, Ltd., an AI echocardiography company based in Oxford, England, is highly accurate in screening for cardiac amyloidosis, a ...
This transcript has been edited for clarity. Gayatri Acharya, MD: Greetings. I'm Dr Gayatri Acharya, cardiology fellow at Mayo Clinic. During today's roundtable, we'll be discussing cardiac ...
Cardiac amyloidosis is a heart condition in which abnormal proteins build up in the heart muscle, making it stiff and impairing its ability to pump blood. Multiple life-prolonging drug treatments for ...
Every day, your heart works tirelessly, pumping blood that delivers the oxygen and nutrients your body needs to function. February is American Heart Month, a reminder that understanding your heart, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results